Hemostatic Disorders  >>  Torisel (temsirolimus)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Torisel (temsirolimus) / Pfizer
NCT00693433: Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma

Completed
1
15
US
dexamethasone, Aeroseb-Dex, Decaderm, Decadron, DM, DXM, temsirolimus, CCI-779, cell cycle inhibitor 779, Torisel, laboratory biomarker analysis
National Cancer Institute (NCI)
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
08/10
 
NCT00398515: Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma

Completed
1
25
US
lenalidomide, CC-5013, IMiD-1, Revlimid, temsirolimus, CCI-779, cell cycle inhibitor 779, Torisel, pharmacological study, pharmacological studies, laboratory biomarker analysis
National Cancer Institute (NCI)
Refractory Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
02/12
 

Download Options